at the implant-bone interface by In finite platform


Severe health complications stem from the lack of understanding of implant-tissue interactions. Use the following platform to identify implant-associated risks and optimize the efficiency of their modulators:

Clinical-data-calibrated osteolysis In finite platform predicting bone loss in human patients based on early in vitro events.

Class of novel IATA NAM test method


Application 1 – by implant manufacturers…   

for long-term safety assessment of new and existing implant materials by enlightening health complications such as aseptic loosening due to debris-induced osteolysis. 


Application 2 – by pharmaceutical companies…

…for testing efficacy and elucidating the mode-of-action of compounds designed to modulate processes such as inflammation, degradation and building of bone.